Effects of Prevena Therapy on Obese and or Diabetic Patients With Surgical Groin Sites
NCT ID: NCT01983215
Last Updated: 2017-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
276 participants
INTERVENTIONAL
2013-04-30
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Intrawound Vancomycin Powder on Surgical Site Infection in Inguinal Lymph Node Dissection
NCT05625373
Prevention of Infections in Cardiac Surgery (PICS) Prevena Study
NCT03402945
Intrapartum Vancomycin for Group B Streptococcus (GBS) Prophylaxis
NCT02143154
Prospective Data Bank Creation to Study Vaginal Conditions
NCT01829204
The Use of Ceftaroline as Surgical Prophylaxis in Surgery With Risk of MRSA Infection
NCT02307006
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
negative pressure dressing vs. standard of care
single arm study- randomized Prevena vac or standard of care
Prevena vac
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prevena vac
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* obese (BMI \> 30) and or diabetic
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Jean E. Starr, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Jean E. Starr, MD
Vascular surgeon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean E Starr, MD
Role: PRINCIPAL_INVESTIGATOR
The Ohio State Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ohio State Division of Vascular Diseases and Surgery
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013H0045
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.